CanStem Therapeutics

Cancer is a deadly disease and represents a key drug development market. We strive to develop innovative therapies with lifesaving benefits to cancer patients.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Lausanne, Switzerland
  • Currency CHF
  • Founded 2014
  • Employees 1

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free